Delivery Order SPE2DB20D2104-SPE2DB23FR15P
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,373.13 firm fixed-price delivery order is for the supply of Moxifloxacin 0.5% eye drops with a period of performance through July 15, 2022. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that...
- This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of moxifloxacin 0.5% eye drops in 3ml vials. The $1,051.23 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, on November 17, 2022, with a completion date of November 18, 2022. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for moxifloxacin 0.5% eye drops in a 3 milliliter formulation with a ceiling value of $1,075.80. This competitively awarded, firm fixed-price delivery order was issued on August 22, 2025, with an ultimate completion date of August 25, 2025. The order will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award, with a ceiling value of $5,923.88, is a Delivery Order under Contract SPE2DX15D3005|SPE2DX24F3RHQ for the supply of MOXIFLOXACIN 0.5% EYE DROPS 3ML to the Defense Logistics Agency (DLA) Troop Support Medical, which is the primary agency for this contract. The contract is a Firm Fixed Price agreement with an ultimate completion date of May 7,...
- The Defense Logistics Agency awarded a delivery order valued at $359.78 to Amerisourcebergen Drug Corp under an indefinite-delivery/indefinite-quantity contract vehicle. The firm fixed price order is for 4561889589 units of Moxifloxacin 0.5% eye drops to be delivered from the contractor's facility in Conshohocken, Pennsylvania to an unknown customer by August 22, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corp, which will serve as the prime contractor...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $6,514.78 firm fixed price delivery order contract to provide the pharmaceutical product moxifloxacin hydrochloride. The award has a completion date of February 7, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $635 to Amerisourcebergen Drug Corporation for 0.5% moxifloxacin eye drops. As the prime contractor, Amerisourcebergen will supply 3mL bottles of the ophthalmic solution to meet requirements under the agency's pharmaceutical procurement programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day in September 2023. No subcontractors or set...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,585.38 firm fixed-price delivery order is for the supply of Moxifloxacin Hydrochloride, a broad-spectrum antibiotic medication. The contract has an ultimate completion date of February 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency Troop Support Medical awarded a $271.08 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4562261059 MOXIFLOXACIN 0.5% EYE DROPS 3ML. Performance will take place in Conshohocken, Pennsylvania under the contract ending September 22, 2023. Amerisourcebergen Corporation is the parent company of the prime contractor. No subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the global...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $8,103.30 contract is for the delivery of the pharmaceutical product Moxifloxacin Hydrochl by the completion date of December 26, 2023. Amerisourcebergen Drug Corp, as the prime contractor, provides a wide range of pharmaceuticals and medical supplies to...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FR15PDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4559143810 - Moxifloxacin 0.5% Eye Drops 3ML. The firm fixed-price contract, valued at $1,175.16, has a completion date of November 21, 2022. This contract is not a set-aside and was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract includes critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/18/22 |